Relationship between serum 25-hydroxy vitamin D levels and retinopathy of prematurity

Scott Med J. 2017 Nov;62(4):129-135. doi: 10.1177/0036933017701867. Epub 2017 Sep 13.

Abstract

Aim To evaluate the relationship between serum 25-hydroxy vitamin D, 25 (OH) D, levels and retinopathy of prematurity. Methods and Results Serum 25 (OH) D levels were measured in 97 very low birth weight infants, prior to vitamin D supplementation. The development of retinopathy of prematurity and its treatment requirement were evaluated. At follow-up, retinopathy of prematurity developed in 71 (73.2%) infants. Serum 25 (OH) D levels were significantly lower in infants with retinopathy of prematurity than ones without retinopathy of prematurity ( P < 0.001). The infants who required treatment had lower 25 (OH) D levels compared with the infants who did not required treatment (7.1 ± 5.2 ng/ml vs. 11.9 ± 6.5 ng/ml; P = 0.003). Multivariate analysis showed that lower serum 25 (OH) D levels may be a risk factor for retinopathy of prematurity development [OR: 1.14, 95% CI (1.02-1.27), P = 0.02]. Conclusion Lower 25 (OH) D levels in the first days of life may be related to retinopathy of prematurity development and treatment requirement in premature infants.

Keywords: Preterm; retinopathy of prematurity; vitamin D.

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Bevacizumab / therapeutic use*
  • Dietary Supplements
  • Follow-Up Studies
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Infant, Very Low Birth Weight
  • Intravitreal Injections
  • Light Coagulation
  • Odds Ratio
  • Prospective Studies
  • Retinopathy of Prematurity / blood*
  • Retinopathy of Prematurity / epidemiology
  • Retinopathy of Prematurity / etiology
  • Risk Factors
  • Treatment Outcome
  • Turkey / epidemiology
  • Vitamin D / analogs & derivatives*
  • Vitamin D / blood
  • Vitamin D / therapeutic use
  • Vitamin D Deficiency / blood*
  • Vitamin D Deficiency / complications
  • Vitamin D Deficiency / epidemiology

Substances

  • Angiogenesis Inhibitors
  • Vitamin D
  • Bevacizumab
  • 25-hydroxyvitamin D